So we are looking at 5yrs before commercializing the product right? But why is PRR (Presentation) talking about the Ovarian Cancer market for 2010 is $360 million (10% of their target)? Shouldn't they talk about market for 2013 etc.?
Doesn't make sense?
time to hear from management, page-10
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.3¢ |
Change
-0.013(3.09%) |
Mkt cap ! $570.1M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 40.8¢ | 39.0¢ | $1.078M | 2.730M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 58462 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 96521 | 21 |
View Market Depth
| Last trade - 14.53pm 02/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |